gvtcx

LaCaR Reagents for cancer service

Birmingham Women's and Children's NHS Foundation Trust Published 6 May 2025 Find a Tender

key details

Statuscomplete
Proceduredirect
OCIDocds-h6vhtk-050cf1

Award

SupplierValueDateStatus
LaCAR MDx Technologies · · active

description

The kit has been validated in house and replaces the previous analysis done by Agena as offers a faster TAT to deliver results within 5 calendar days directly from blood.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
6 May 2025 Contract details (UK7) Procurement Act 2023 019029-2025

more from Birmingham Women's and Children's NHS Foundation Trust

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.